Komori
Other Disclosures4882Perseus Proteomics Inc.Pharmaceuticals

Notice of a Nihonbashi Lab Tour for Individual Shareholders

A tour of the Company's head office and Nihombashi Lab will be held for individual shareholders on 24 October 2026. Participation is free, and approximately 16 places will be available.

Worth reading
41Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
16
People, approximately
Wording
Conditional
How definitive the wording is.

Announced details

Applicable field (uses covered by this announcement)

Tour of the Company's head office and Nihombashi Lab for individual shareholders and interaction with employees

Launch date24 October 2026 (Saturday), 10:00–12:00 (予定)
Relationship between the counterparty and the company
Perseus Proteomics Inc.4882
Relationship with the Company

This is a tour for individual shareholders. Eligible participants are individual shareholders who held 100 or more shares of the Company as of 30 September 2026 and can be verified in the shareholder register.

Location (as indicated in this announcement)

30-1 Nihombashi Hakozaki-cho, Chuo-ku, Tokyo, A.i.Nihombashi EAST, 3rd floor (the Company's head office/Nihombashi Lab)

Approximately 16 places available; approximately 2 hours
Offering price

Free of charge (participants are responsible for their own transportation expenses)

The company does not address Contract Value / Impact on Business Performance.

Announced details
ItemDetails
Relationship with the CompanyThis is a tour for individual shareholders. Eligible participants are individual shareholders who held 100 or more shares of the Company as of 30 September 2026 and can be verified in the shareholder register.
Offering priceFree of charge (participants are responsible for their own transportation expenses)
Launch date24 October 2026 (Saturday), 10:00–12:00 (予定)
Applicable areaTour of the Company's head office and Nihombashi Lab for individual shareholders and interaction with employees
Location30-1 Nihombashi Hakozaki-cho, Chuo-ku, Tokyo, A.i.Nihombashi EAST, 3rd floor (the Company's head office/Nihombashi Lab)
Location scaleApproximately 16 places available; approximately 2 hours
Items this document does not state (12)
Names of Products / Services CoveredCounterpartyCounterparty overviewContract ValueContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateQuantitative EffectsUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To deepen individual shareholders' understanding of the value of the Company's business through a tour of the Company's head office and Nihombashi Lab and interaction with employees.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of a Nihonbashi Lab Tour for Individual Shareholders | Perseus Proteomics Inc. (4882) timely disclosure | Komori